CLINICALLY PROVEN RESULTS
Phase II Clinical Trial Study Highlights
The results stated are the findings of a six-month long, Phase II, double-blind clinical trial conducted on the EverYoung GH-2000 ng/ml plant-based polymer matrix oral GH spray formulation.
IGF-1 levels: 100%+ Increase
Ever Young GH-2000 produced significant positive improvement on the study participants' IGF-1 levels. Over the six month study period male participants' experienced a 109% positive improvement in their IGF-1 levels, while female participants' experienced a 102% positive improvement in their IGF-1 levels.
ADDITIONAL HIGHLIGHTS
LDL (bad cholesterol) Levels: 20%+ Decrease
EverYoung GH-2000 produced significant positive improvement on the study participants' LDL levels. Over the six-month study period, male participants' experienced a 23% decrease and female participants' experienced a 20'% decrease in their LDL levels
HDL Levels: (good cholesterol)
Females 47% Increase & Males 93% Increase
EverYoung GH-2000 produced significant positive improvement on the study participants' HDL levels. Over the six-month study period, male participants' experienced a 93% increase and female participants' experienced a 47% increase in their HDL levels.
Triglyceride Levels: 35% to 40% Decrease
Ever Young GH-2000 produced significant positive improvement on the study participants' triglyceride levels. Over the six-month study period, male participants' experienced a 35%, decrease and female participants' experienced a 40% decrease in their triglyceride levels.
Patients receiving the GH-2000 showed notable increases in:
Mental acuity
Muscle accretion
Weight reduction
Higher energy
Elevated libido
Epidermis rejuvenation
Reacquired hair color and density
No adverse side affects were noted in either placebo or test groups
EverYoung Nutritionals
EverYoung-CTK is Anti-Spam! No Customer or Visitor information will be used or sold for SPAM!
